comparemela.com
Home
Live Updates
Acumen Pharmaceuticals Presents Positive Topline Results : comparemela.com
Acumen Pharmaceuticals Presents Positive Topline Results
Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid...
Related Keywords
Amsterdam ,
Noord Holland ,
Netherlands ,
New York ,
United States ,
Alex Braun ,
Lawrence Honig ,
Daniel Oconnell ,
Steven Dekosky ,
Jessica Laub ,
Eric Siemers ,
University Of Florida ,
Mcknight Brain Institute ,
York State Center ,
Alzheimer Association International Conference ,
Exchange Commission ,
Alzheimer Disease At Columbia University ,
Nasdaq ,
Research Session ,
Acumen Pharmaceuticals Inc ,
Acumen Pharmaceuticals ,
Drug Administration ,
Association International Conference ,
Danielo Connell ,
Chief Executive Officer ,
Amyloid Plaque ,
Well Tolerated Across Dose ,
Consistent Dose Related Pharmacokinetics ,
Dose Related Target Engagement ,
Statistically Significant ,
Chief Medical Officer ,
Featured Research Session ,
Deputy Director ,
New York State Center ,
Columbia University ,
Fast Track ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Report ,
Nasdaq Abos ,
Nc ,
comparemela.com © 2020. All Rights Reserved.